Mart Ustav | Academic Influence

Mart Ustav's AcademicInfluence.com Rankings

Mart Ustav

Biology

#14846

World Rank

#18708

Historical Rank

Biotechnology

#288

World Rank

#290

Historical Rank

biology Degrees

Download Badge

Biology

Mart Ustav's Degrees

PhD Biomedical Sciences University of Tartu
Masters Biotechnology University of Tartu
Bachelors Biotechnology University of Tartu

Why Is Mart Ustav Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mart Ustav is an Estonian biomedical scientist. Ustav was born Cherlak, Russian SFSR to Estonian parents who had been deported by Soviet authorities. The family were permitted to return to Estonia in 1956, following the death of Joseph Stalin and the Khrushchev Thaw. He attended primary and secondary schools in Tartu and graduated from the Department of Physics and Chemistry of Tartu State University in 1972. In 1979, he defended his doctoral degree in chemistry from the board of the Institute of Molecular Biology and Genetics of the National Academy of Sciences of Ukraine.

(See a Problem?)

Mart Ustav's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Transient replication of BPV‐1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. (1991) (482)
Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study (2021) (394)
Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. (1992) (306)
Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. (1991) (266)
Long-Term Episomal Maintenance of Bovine Papillomavirus Type 1 Plasmids Is Determined by Attachment to Host Chromosomes, Which Is Mediated by the Viral E2 Protein and Its Binding Sites (1999) (205)
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2 (2020) (204)
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses (2009) (184)
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2. (2020) (182)
Cis and trans requirements for stable episomal maintenance of the BPV‐1 replicator. (1996) (170)
The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. (1993) (136)
Engagement of the ATR-Dependent DNA Damage Response at the Human Papillomavirus 18 Replication Centers during the Initial Amplification (2012) (130)
Genomic instability of the host cell induced by the human papillomavirus replication machinery (2007) (114)
Papillomavirus DNA replication - from initiation to genomic instability. (2009) (108)
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2 (2020) (101)
Brd4 Is Involved in Multiple Processes of the Bovine Papillomavirus Type 1 Life Cycle (2006) (93)
New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids. (2013) (85)
Human Papillomavirus Type 18 E1 Protein Is Translated from Polycistronic mRNA by a Discontinuous Scanning Mechanism (1999) (77)
RIG-I and MDA-5 Detection of Viral RNA-dependent RNA Polymerase Activity Restricts Positive-Strand RNA Virus Replication (2013) (74)
Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 (2021) (73)
Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants (1996) (71)
The Basis of Prostaglandin Synthesis in Coral (2001) (61)
Analysis of Chromatin Attachment and Partitioning Functions of Bovine Papillomavirus Type 1 E2 Protein (2004) (57)
p53 Protein Is a Suppressor of Papillomavirus DNA Amplificational Replication (1998) (55)
Increased circulating concentrations of mesencephalic astrocyte-derived neurotrophic factor in children with type 1 diabetes (2016) (52)
Persistent immune responses induced by a human immunodeficiency virus DNA vaccine delivered in association with electroporation in the skin of nonhuman primates. (2009) (51)
Predominance of a Rare Type of HIV-1 in Estonia (2005) (51)
Functional Domains of the TOL Plasmid Transcription Factor XylS (2000) (48)
Mapping of Betapapillomavirus Human Papillomavirus 5 Transcription and Characterization of Viral-Genome Replication Function (2013) (46)
Development of a Cellular Assay System To Study the Genome Replication of High- and Low-Risk Mucosal and Cutaneous Human Papillomaviruses (2011) (45)
Association of cagA and vacA Genotypes of Helicobacter pylori with Gastric Diseases in Estonia (2002) (45)
Human papillomavirus E2 protein with single activation domain initiates HPV18 genome replication, but is not sufficient for long-term maintenance of virus genome. (2010) (44)
The Cell Cycle Timing of Human Papillomavirus DNA Replication (2015) (44)
The Cell Cycle Timing of Human Papillomavirus DNA Replication (2015) (44)
Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques (2017) (43)
The E5 gene of bovine papillomavirus type 1 is sufficient for complete oncogenic transformation of mouse fibroblasts. (1988) (39)
Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and mice (2019) (38)
Identification and Tracking of Antiviral Drug Combinations (2020) (37)
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU(®)-Multi-HIVB, in untreated HIV-1 infected subjects. (2012) (37)
Identification and Tracking of Antiviral Drug Combinations (2020) (37)
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins (2018) (37)
Effect of Bovine Papillomavirus E2 Protein-Specific Monoclonal Antibodies on Papillomavirus DNA Replication (1999) (36)
Characterization of the Functional Activities of the Bovine Papillomavirus Type 1 E2 Protein Single-Chain Heterodimers (2006) (34)
TOL plasmid transcription factor XylS binds specifically to the Pm operator sequence (1996) (32)
Recombination-Dependent Oligomerization of Human Papillomavirus Genomes upon Transient DNA Replication (2013) (32)
Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH. (2005) (29)
A DNA HIV-1 vaccine based on a fusion gene expressing non-structural and structural genes of consensus sequence of the A-C subtypes and the ancestor sequence of the F-H subtypes. Preclinical and clinical studies. (2005) (29)
Induction of the Bovine Papillomavirus Origin “Onion Skin”-Type DNA Replication at High E1 Protein Concentrations In Vivo (2002) (29)
The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells (2014) (28)
The Transcription Map of Human Papillomavirus Type 18 during Genome Replication in U2OS Cells (2014) (28)
Episomal Maintenance of Plasmids with Hybrid Origins in Mouse Cells (2005) (28)
The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome (2015) (27)
Complex formation between hepatitis C virus NS2 and NS3 proteins. (2006) (27)
Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine. (2006) (27)
Coinfection of Chlamydia trachomatis, Ureaplasma urealyticum and human papillomavirus among patients attending STD clinics in Estonia (2007) (25)
DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector. (2001) (25)
Identification and Analysis of Papillomavirus E2 Protein Binding Sites in the Human Genome (2011) (24)
Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia. (2000) (24)
Association of Bovine Papillomavirus E2 Protein with Nuclear Structures In Vivo (2005) (23)
Initial amplification of the HPV18 genome proceeds via two distinct replication mechanisms (2015) (22)
DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost (2018) (20)
HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species (2016) (20)
HybriFree: a robust and rapid method for the development of monoclonal antibodies from different host species (2016) (20)
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay (2017) (19)
Identification of several high-risk HPV inhibitors and drug targets with a novel high-throughput screening assay (2017) (19)
Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. (2003) (19)
Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV--study in domestic pigs. (2009) (18)
Monitoring and purification of proteins using bovine papillomavirus E2 epitope tags. (2000) (18)
Activity of CK2α protein kinase is required for efficient replication of some HPV types (2019) (18)
Inhibition of the bovine papillomavirus E2 protein activity by peptide nucleic acid. (2000) (18)
Diversity of Helicobacter pylori genotypes among Estonian and Russian patients with perforated peptic ulcer, living in Southern Estonia. (2001) (15)
Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency (2015) (15)
Bovine papillomavirus type 1 E2 protein heterodimer is functional in papillomavirus DNA replication in vivo. (2009) (15)
Human Papillomavirus Type 18 cis-Elements Crucial for Segregation and Latency (2015) (15)
Humoral and cellular immune responses to HIV-1 nef in mice DNA-immunised with non-replicating or self-replicating expression vectors. (1999) (14)
Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells (2020) (14)
Cell-Specific Modulation of Papovavirus Replication by Tumor Suppressor Protein p53 (2000) (14)
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations (2020) (13)
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations (2021) (13)
Biochemical and proteomic characterization of retrovirus Gag based microparticles carrying melanoma antigens (2016) (13)
Roles of the hinge region and the DNA binding domain of the bovine papillomavirus type 1 E2 protein in initiation of DNA replication. (2001) (12)
Functional Characterization of Fingers Subdomain-specific Monoclonal Antibodies Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase* (2008) (12)
Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents (2021) (11)
Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins (2018) (11)
Effective Formation of the Segregation-Competent Complex Determines Successful Partitioning of the Bovine Papillomavirus Genome during Cell Division (2010) (11)
Bovine colostrum-derived antibodies against SARS-CoV-2 show great potential to serve as prophylactic agents (2021) (11)
Analysis of Human Papillomavirus Genome Replication Using Two‐ and Three‐Dimensional Agarose Gel Electrophoresis (2017) (11)
Hepatitis C virus genotypes in Estonia (2000) (11)
Distribution of Acinetobacter baumannii in a neurointensive care unit. (1999) (10)
DNA Transfer into Animal Cells Using Stearylated CPP Based Transfection Reagent. (2015) (10)
Bovine papilomavirus oncoprotein E5 induces the NFκB activation through superoxide radicals (1996) (9)
Bovine papillomavirus oncoprotein E5 affects the arachidonic acid metabolism in cells. (2001) (9)
DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells (2015) (9)
Declined antibody responses to COVID-19 mRNA vaccine within first three months (2021) (9)
Efficient transfection of novel bovine papillomavirus 1 expression plasmids. (2001) (9)
High Prevalence of The CCR5Δ32 HIV-Resistance Mutation among Estonian HIV Type 1-Infected Individuals (2007) (9)
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line (2002) (8)
Nuclear myosin 1 associates with papillomavirus E2 regulatory protein and influences viral replication. (2018) (8)
Nuclear myosin 1 associates with papillomavirus E2 regulatory protein and influences viral replication. (2018) (8)
Molecular Studies of HPV-18 Genome Segregation and Stable Replication (2016) (8)
Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma (2018) (8)
Bovine papillomavirus oncoprotein E5 induces the NF kappa B activation through superoxide radicals. (1996) (7)
Innate Molecular and Cellular Signature in the Skin Preceding Long-Lasting T Cell Responses after Electroporated DNA Vaccination (2020) (7)
A quaternary complex consisting of two molecules of tRNA and ribosomal proteins L2 and L17 (1981) (6)
Characterization of the nuclear matrix targeting sequence (NMTS) of the BPV1 E8/E2 protein — the shortest known NMTS (2015) (6)
Replication of a chimeric origin containing elements from Epstein-Barr virus ori P and bovine papillomavirus minimal origin. (2001) (6)
The interaction of ribosomal protein L16 and its fragments with tRNA (1983) (6)
The interaction of 5 S RNA and its large fragments with ribosomal proteins (1981) (5)
ACE2 Peptide Fragment Interaction with Different S1 Protein Sites (2021) (5)
Protective antibodies and T cell responses to Omicron variant after the booster dose of BNT162b2 vaccine (2022) (5)
Uncovering the Role of the E1 Protein in Different Stages of Human Papillomavirus 18 Genome Replication (2020) (5)
Identification of the immunodominant regions of the melanoma antigen tyrosinase by anti-tyrosinase monoclonal antibodies (2003) (5)
Differential phosphorylation determines the repressor and activator potencies of GLI1 proteins and their efficiency in modulating the HPV life cycle (2019) (5)
Production of functional recombinant tyrosine hydroxylase by the BPV-1 expression plasmids in the cell cultures. (2003) (4)
Effective generation of transgenic mice by Bovine papillomavirus type 1 based self-replicating plasmid that is maintained as extrachromosomal genetic element in three generations of animals. (2003) (4)
High prevalence of the CCR5Delta32 HIV-resistance mutation among Estonian HIV type 1-infected individuals. (2007) (4)
E2 protein is the major determinant of specificity at the human papillomavirus origin of replication (2019) (4)
Analysis of the Replication Mechanisms of the Human Papillomavirus Genomes (2021) (4)
Bovine papillomavirus type 1 oncoprotein E5 stimulates the utilization of superoxide radicals in the mouse fibroblast cell line C127. (2006) (3)
Predicting Transiently Expressed Protein Yields: Comparison of Transfection Methods in CHO and HEK293 (2022) (3)
5S RNA‐Protein complex is involved in ribosomal subunit association (1983) (3)
Organization and expression of the genome of bovine papillomavirus type 1. (1986) (3)
Prevalence of ticks infected with Borrelia burgdorferi in Estonia (1999) (3)
The molecular biology and HPV drug responsiveness of cynomolgus macaque papillomaviruses support their use in the development of a relevant in vivo model for antiviral drug testing (2019) (2)
Replication of the bovine papillomavirus type 1 genome; antisense transcripts prevent episomal replication. (1986) (2)
Cis and Trans Requirements for Bpv DNA Replication (1991) (2)
Protective antibodies and T cell responses to Omicron variant three months after the booster dose of BNT162b2 vaccine (2022) (2)
Identification of novel antiviral drug combinations in vitro and tracking their development (2020) (2)
The bovine papillomavirus origin of replication requires a binding site for the E 2 transcriptional activator ( DNA replication / transcription factor ) (1)
CuZn‐SOD suppresses the bovine papillomavirus‐induced proliferation of fibroblasts (2007) (1)
DNA Transfer into Animal Cells Using Stearylated CPP Based Transfection Reagent. (2021) (1)
Tyrosine hydroxylase gene transfer to rat striatum using Bovine Papilloma Virus-1 expression plasmids in the experimental model of Parkinson's disease (2001) (1)
Cyclic AMP-Dependent Protein Kinase Exhibits Antagonistic Effects on the Replication Efficiency of Different Human Papillomavirus Types (2021) (1)
ACE2 peptide fragment interacts with several sites on the SARS-CoV-2 spike protein S1 (2020) (1)
OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques (2009) (1)
Author response: Tailored tetravalent antibodies potently and specifically activate Wnt/Frizzled pathways in cells, organoids and mice (2019) (1)
332 The Anti-tyrosinase Monoclonal Antibody is Effective in Treating Mice Bearing Syngenic Melanoma (2012) (1)
Expressed therapeutic protein yields are predicted by transiently transfected mammalian cell population (2022) (0)
P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides (2009) (0)
[Expression of human tissue plasminogen activator by recombinant cell lines from various animals]. (1991) (0)
Victor de Lorenzo and Mart Ustav Transcription Factor XylS Functional Domains of the TOL Plasmid (2000) (0)
A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line: Correction (2002) (0)
[Comparison of vector properties of the usual and modified sequences of the BPV-1 genome]. (1991) (0)
P17-11. HIV DNA vaccine delivery in association with electroporation in the skin of nonhuman primates (2009) (0)
The expression vector uses thereof and a process for its preparation and products containing it (2001) (0)
Abstract 6036: Functional antibodies against multi span transmembrane proteins - revisiting the Warburg effect in cancer cells (2023) (0)
P19-30. GTU® as beneficial HIV DNA vaccine vector system (2009) (0)
Improvement of recombinant ADAMTS13 production through a more optimal signal peptide or an N‐terminal fusion protein (2022) (0)
MANF regulates neuronal survival and UPR through its ER-located receptor IRE1α. (2023) (0)
Viral E2 Protein and Its Binding Sites Chromosomes, Which Is Mediated by the Determined by Attachment to Host Bovine Papillomavirus Type 1 Plasmids Is Long-Term Episomal Maintenance of (2013) (0)
[Expression of human tissue-type plasminogen activator cDNA in human cultured cells controlled by different eukaryotic promoters]. (1989) (0)
Mart Ustav the Human Genome Papillomavirus E 2 Protein Binding Sites in Identification and Analysis of (2011) (0)
Transfection of BPV-LAC Z plasmids in primate CV1-P and SH-SY5Y cell cultures (1998) (0)
The transcription map of HPV11 in U2OS cells adequately reflects the initial and stable replication phases of the viral genome (2015) (0)
DAXX modulates human papillomavirus early gene expression and genome replication in U2OS cells (2015) (0)
[Recombinant murine cell lines, transformed by various vectors based on bovine type 1 papillomavirus and expressing human tissue plasminogen activator. II. Analysis of cell lines, producing recombinant tissue plasminogen activator]. (1994) (0)
DNA-launched RNA replicon vaccines induce potent anti-Ebolavirus immune responses that can be further improved by a recombinant MVA boost (2018) (0)
Table of Contents (1996) (0)
The new selection system useful in a vector, bacterial cell strains and a method to select cells (2003) (0)
Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques (2017) (0)
Selection system containing a selection marker is not antibiotic resistance (2004) (0)

This paper list is powered by the following services:

Other Resources About Mart Ustav

en.wikipedia.org

What Schools Are Affiliated With Mart Ustav?

Mart Ustav is affiliated with the following schools:

Image Attributions

Image Source for Mart Ustav